A Phase 2b Study of GCS-100 in Patients With Chronic Kidney Disease Caused by Diabetes
Clinical trial NCT02312050 · UNKNOWN
Trial details
- NCT number
- NCT02312050
- Sponsor
- La Jolla Pharmaceutical Company
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2016-09-01
- Enrollment
- 375
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.